According to Zhitong Finance App News, Hualing Pharmaceutical-B (02552.HK) issued an announcement. On August 21, 2026, the Company granted 200,000 share options to an employee (grantor) of the Company based on the Company's share option plan, which was conditionally approved and adopted on August 26, 2018 and effective on September 14, 2018, but only after acceptance by the grantor. The share option grants the grantor the right to subscribe for 200,000 new shares with a face value of $0.001 per share in the Company's share capital.

According to Zhitong Finance App News, Hualing Pharmaceutical-B (02552.HK) issued an announcement. On August 21, 2026, the Company granted 200,000 share options to an employee (grantor) of the Company based on the Company's share option plan, which was conditionally approved and adopted on August 26, 2018 and effective on September 14, 2018, but only after acceptance by the grantor. The share option grants the grantor the right to subscribe for 200,000 new shares with a face value of $0.001 per share in the Company's share capital.